"We are witnessing a revolution of what it means to be diseased." @​zavaindar believes biotech is entering a new era where conditions once dismissed as behavio

"We are witnessing a revolution of what it means to be diseased." @​zavaindar believes biotech is entering a new era where conditions once dismissed as behavioral or insignificant are becoming major targets for new drugs. "10 or 15 years ago, pharma and biotech didn't invest in [obesity] because t…